Lyell Immunopharma Inc LYEL Balance Sheet

Income Statement

Quarter End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	1.02B	977.27M	937.56M	880.45M	835.35M	794.99M	750.03M	694.22M
Total Current Assets	666.78M	659.75M	651.3M	624.4M	606.41M	586.85M	554.69M	534.17M
Cash and Equivalents	205.74M	116.31M	123.55M	109.43M	224.37M	286.21M	145.65M	125.65M
Total Non-Current Assets	354.9M	317.52M	409.29M	256.05M	228.94M	208.14M	298M	160.06M
Total Liabilities	153.63M	157.24M	104.31M	96.62M	98.5M	97.42M	95.08M	91.06M
Total Current Liabilities	50.29M	51.22M	37.03M	30.8M	34.39M	35.06M	34.52M	32.35M
Total Non-Current Liabilities	103.34M	106.03M	67.28M	65.83M	64.11M	62.35M	60.56M	58.71M
Common Equity	25k	25k	25k	25k	25k	25k	25k	25k
Retained Earnings	-688.83M	-759.08M	-767.48M	-834.44M	-898.33M	-949.18M	-1B	-1.06B

Year End December 30 2023	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	555.63M	908.28M	1.13B	937.56M	750.03M
Total Current Assets	440.26M	617.55M	626.29M	651.3M	554.69M
Cash and Equivalents	96.67M	140.41M	293.83M	123.55M	145.65M
Total Non-Current Assets	-111.11M	-292.53M	929.79M	833.25M	654.95M
Total Liabilities	147.58M	189.84M	197.62M	104.31M	95.08M
Total Current Liabilities	22.05M	49.29M	46.74M	37.03M	34.52M
Total Non-Current Liabilities	125.53M	140.56M	150.88M	67.28M	60.56M
Total Equity	-111.11M	-292.53M	929.79M	833.25M	654.95M
Common Equity	1,000	2k	24k	25k	25k
Retained Earnings	-129.67M	-334.14M	-584.36M	-767.48M	-1B